Position in NVO
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$202,546
New position
Shares Held
4,225
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,036
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Congress Park Capital LLC holds $10,199,729 across 8 Drug Manufacturers - General names. NVO ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,607 | $4,326,344 | |
| 2 | AMGN |
Amgen Inc
|
5,130 | $1,857,675 | |
| 3 | JNJ |
Johnson & Johnson
|
6,838 | $1,736,646 | |
| 4 | ABBV |
AbbVie Inc.
|
3,637 | $915,214 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,060 | $650,210 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,225 | $281,106 | |
| 7 | PFE |
Pfizer Inc
|
9,551 | $229,988 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
4,225 | $202,546 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202,546 | 4,225 | Shares | Sole | 2026-07-14 | |
| No filing history on record for this holder in this stock. | ||||||